Logo of IDEXX Laboratories (NASDAQ:IDXX)Latest IDEXX Laboratories (NASDAQ:IDXX) News

Page 1
Page 1 of 1

IDEXX lifts 2026 guidance as diagnostics demand drives a powerful third quarter

IDEXX Laboratories has raised its 2026 revenue and earnings outlook after reporting 10% third-quarter revenue growth and an 18% rise in diluted EPS. The upgrade came alongside rapid adoption of its inVue Dx analyzers, although acquisition costs prompted a lower full-year operating margin forecast.
Ada Torres
2 Nov 2026